FDA Import Refusal 799-7823960-8/10003/1 — Boehringer Ingelheim Canada
The FDA refused shipment 799-7823960-8/10003/1 from Boehringer Ingelheim Canada (Canada) on Nov 21, 2025. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 21, 2025
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCB73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75